Home/Healthcare/Surgery/Surgical Oncology Market

Surgical Oncology Market - Strategic Insights and Forecasts (2026-2031)

Market Size, Share, Forecasts and Trends Analysis By Procedure Type (Tumor Removal Surgery, Debulking Surgery, Palliative Surgery, Reconstructive Surgery, Preventive (Prophylactic) Surgery, Diagnostic Surgery (Biopsy)), By Indication (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Gynecologic Cancer, Head & Neck Cancer, Others), By End-User (Hospitals, Specialty Cancer Centers, Ambulatory Surgical Centers, Others), and Geography

Market Size in 2026
USD 9.70 billion
Market Size in 2031
USD 14.1 billion
CAGR
7.8 %
Study Period
2021-2031
$3,950
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

πŸ“ž

Your data is secure. We do not share information with any third party.

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Report IDKSI-008575
PublishedMay 2026
Pages154
FormatPDF, Excel, PPT, Dashboard
Frequently Asked Questions

The Surgical Oncology Market is projected to grow from USD 9.70 billion in 2026 to USD 14.1 billion by 2031, according to this report. This represents a compound annual growth rate (CAGR) of 7.8% over the forecast period, driven by technological advancements and rising cancer incidence.

This report highlights that breast and colorectal cancer surgeries account for a substantial share of global surgical oncology procedures. This is primarily due to their high disease prevalence and the existence of established surgical protocols, making them key segments within the market.

The market is undergoing significant transformation driven by advancements such as minimally invasive techniques like laparoscopic and robotic surgeries, and image-guided surgical systems. These innovations enhance intraoperative accuracy, improve precision in tumor resection, and lead to reduced complications and shorter patient recovery times.

The report identifies the rising global incidence of cancers, particularly breast, lung, and colorectal cancer, as a primary driver due to increased demand for surgical intervention. Additionally, continuous technological advancements in surgical systems and a growing patient and healthcare provider preference for minimally invasive procedures are accelerating market growth.

This report indicates that the integration of surgical oncology with systemic therapies such as chemotherapy and radiotherapy is a major trend. This multidisciplinary approach is crucial for improving overall survival rates and effectively reducing recurrence risk, particularly in complex cancer cases, enhancing patient outcomes.

Specialty cancer centers are rapidly adopting advanced surgical platforms, including robotic and minimally invasive technologies, positioning themselves as key hubs for complex oncology procedures. This adoption is driven by improved dexterity, visualization, and surgeon control, which enhances precision in tumor removal and optimizes hospital resource utilization.

Need data specifically for your business?Request Custom Research β†’
Related Reports

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon